A retrospective analysis of colorectal carcinoma
received by the Institute for Pathology, University of Pretoria.
However, very little is known about its expression in colorectal carcinomas
PET/CT is currently the preferred method for staging and restaging of patients with colorectal carcinoma
is believed to develop through the accumulation of multiple mutations, either germ line and/or somatic, occurring in oncogenes, tumor suppressor genes, and DNA repair genes.
Hepatic resection following systemic chemotherapy for metastatic colorectal carcinoma
Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma
The company is conducting Phase II studies of IMC-C225 in combination with standard therapies in refractory colorectal carcinoma
and refractory head and neck carcinoma, pancreatic carcinoma and non-small cell lung carcinoma.
Immatics' pipeline also includes IMA910 for the treatment of colorectal carcinoma
which has recently entered a large Phase I/II clinical trial.
To prevent Colorectal Carcinoma
, the government should provide Colonocopes to each District Hospital for early detection of Colon Cancer, they pleaded and also suggested the involvement of print and electronic media for dissemination of this message to the masses for prevention of 3040 percent preventable cancers.
The chronic inflammatory state in patients with IBD places them at a greater risk for developing colorectal carcinoma
A randomized, double-blind, phase (Ph) III study of the irinotecan-based chemotherapy FOLFIRI plus ramucirumab (RAM) or placebo (PL) in patients (pts) with metastatic colorectal carcinoma
(mCRC) progressive during or following first-line therapy with bevacizumab (BEV), oxaliplatin (OXALI), and a fluoropyrimidine (FP)(RAISE)(NCT01183780).
Bacterial endocarditis associated with colorectal carcinoma
American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma
to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy.
In this study, we analyzed 1970 colorectal carcinoma
tumors for KRAS mutations by direct sequencing.
Another study led by sports physician Martin Halle also showed that regular walking lowers the risk of colorectal carcinoma